Search the Newsreel

Is Immunocore Stock Attractive After Kimmtrak's Strong Sales Growth?

Immunocore Holdings (IMCR) presents a mixed investment profile despite strong Kimmtrak sales growth, with revenues up 14% year-over-year but missing analyst estimates. The company maintains a robust cash position of $844.9 million, funding a pipeline of late-stage and early-stage programs. However, its valuation trades …

Bitmine Nears Goal of Controlling 5% of Ethereum Supply With $11.8 Billion Treasury

Crypto treasury firm BitMine Immersion Technologies said Sunday it has increased its Ethereum holdings to 5.79 million ETH, bringing its combined crypto holdings, cash, marketable securities, and strategic investments to $11.8 billion as it moves closer to its goal of acquiring 5% of Ethereum's …

ImmuCell Corp (ICCC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of ImmuCell Corp's (ICCC) dividend history, noting that the company has not distributed any dividends over the past five years. It presents current stock price information and links to more detailed financial and corporate data. The page indicates that …

Shimmick Corp (SHIM) Cash Flow

This article provides the quarterly and annual cash flow statements for Shimmick Corp (SHIM), detailing its operating, investing, and financing cash flows. It includes a tabular presentation of financial data for various quarters and years, alongside frequently asked questions that define different types of …

Immersion Corp (IMMR) Reports Q4 Results; GF Score™ at 58 Reflects Mixed Financial Health

Immersion Corporation (IMMR) reported a decline in Q4 revenue to $270.0 million from $284.9 million year-over-year, alongside a GAAP EPS of $0.30. The company's GF Score™ of 58/100 indicates moderate financial health, with strong profitability (8/10) but concerns in financial strength (5/10) and valuation …

Strategy Climbs 3%, BitMine Surges 7%, SharpLink Rises 5% as Crypto Stocks Bounce Back Toward $65K Bitcoin

Quick Read A U.S. Iran strike pause triggered a relief rally, lifting MSTR 6% and BMNR 13%, but both stocks remain negative over the past year. SharpLink's institutional ownership surged from 6% to 46%, and its $125 million Galaxy Digital (GLXY) on-chain yield fund …

Bitmine Buys Another 10,000 Ethereum

Bitmine Buys Another 10,000 Ethereum Bitmine Immersion Technologies (NYSE: $BMNR) purchased another 10,000 Ethereum (CRYPTO: $ETH) over the past week. Bitmine Chairman Tom Lee said on social media that despite the depressed price, Ethereum has been outperforming Bitcoin (CRYPTO: $BTC) lately, which is a …

Immix Biopharma Inc (IMMX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of dividend and stock split information for Immix Biopharma Inc (IMMX). It notes that the company has not distributed any dividends over the past five years. The page also presents current stock data, including its market cap and recent …

IMRN|Immuron Ltd|Price:1.110|Chg%:-0.060

This TradingKey analysis of Immuron Ltd (IMRN) focuses on its stock performance and proprietary stock score. The article details how TradingKey generates its comprehensive stock score based on 34 indicators across six dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and …

Bitmine Immersion Technologies reports $11.8B crypto & cash holdings, 5.79M ETH and major buyback

Bitmine Immersion Technologies has announced substantial crypto and cash holdings totaling $11.8 billion, including 5.79 million ETH. The company has also been actively repurchasing its common shares, with 11.6 million shares bought back since July 1 under a $4 billion program, and was added …

Bitmine Immersion (NYSE: BMNR) outlines $11.8B crypto assets and buybacks

Bitmine Immersion Technologies, Inc. (BMNR) reported total crypto, cash, and marketable securities holdings of $11.8 billion as of July 26, 2026. This includes significant Ethereum (ETH) holdings, representing 4.8% of the total ETH supply, with a large portion staked on their MAVAN platform, projecting …

Shimmick wins over $265 million in infrastructure contracts

Shimmick Corporation has secured over $265 million in new infrastructure project awards across water, transportation, and energy sectors. These contracts include a $124 million flood protection project in Northern California, a $42 million wastewater treatment plant expansion in Texas, and approximately $80 million from …

Immunocore Holdings PLC (IMCR) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Immunocore Holdings PLC (IMCR). It notes that the company has distributed $0.00 in dividends over the past five years, indicating no recent payouts. The page also presents current stock performance data, including …

Immunovant Inc (IMVT) Cash Flow

This article provides a detailed cash flow statement for Immunovant Inc (IMVT), covering quarterly and annual data for operating, investing, and financing activities. It presents financial figures such as net income, capital expenditures, and free cash flow, alongside year-over-year percentage changes. The article also …

ImmuCell Corp (ICCC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for ImmuCell Corp (ICCC), detailing its performance by business segments and regional contributions. The data, updated on April 6, shows that the First Defense® product line accounts for the vast majority of its revenue, and the United States …

Immuron CEO Steven Lydeamore Presents at TechKnow Invest Roadshow as Company Advances Polyclonal Antibody Pipeline

Immuron Limited's CEO, Steven Lydeamore, presented at the TechKnow Invest Roadshow, highlighting the company's progress in oral polyclonal antibody therapies. The presentation covered their commercial product Travelan® for travelers' diarrhea, the investigational drug IMM-529 for recurrent Clostridioides difficile infection, and the distributed product ProIBS® …

Immuron (NASDAQ: IMRN) outlines FY26 growth, cash runway and CDI IND plans

Immuron Limited shared an investor update detailing FY26 sales, cash position, and plans for its clinical assets. The company reported global sales revenue of A$7.7 million for FY26, a 6% increase from the previous year, and maintains a strong cash balance of A$10.0 million …

Immersion Will Pay a $0.075 Dividend After 15 Straight Quarters

Immersion Corporation reported its Q4 and fiscal year 2026 financial results, with GAAP net income attributable to stockholders reaching $3.7 million ($0.12 per diluted share) for Q4. The company announced a quarterly dividend of $0.075 per share, its 15th consecutive dividend, to be paid …

Immersion Corporation (Nasdaq: IMMR) grows revenue to $1.7B in fiscal 2026

Immersion Corporation reported its financial results for the fourth quarter and fiscal year ended April 30, 2026, announcing total revenue of $1.7 billion for fiscal 2026, an increase from $1.6 billion in fiscal 2025. This growth was largely due to the consolidation of Barnes …

Immersion Reports Q4 and FY2026 Results: Q4 GAAP Net Income $3.7M, Revenue $270.0M

Immersion (IMMR) reported its financial results for Q4 and fiscal year 2026. For Q4, the company saw GAAP net income of $3.7 million on revenues of $270.0 million, with full-year 2026 revenues reaching $1.73 billion. Key highlights include the financial impact of the Barnes …

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.79 Million Tokens, and Total Crypto and Total Cash Holdings of $11.8 Billion

Bitmine Immersion Technologies (BMNR) announced that its Ethereum (ETH) holdings have reached 5.79 million tokens, contributing to total crypto and cash holdings of $11.8 billion. The company has acquired 4.8% of the total ETH coin supply and is progressing towards its "Alchemy of 5%" …

Press Release: Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors

Immunic, Inc. has appointed Michael W. Bonney as Chair of its Board of Directors. Bonney brings extensive experience from his previous leadership roles at Kaleido Biosciences, Baxalta Inc., and Cubist Pharmaceuticals, as well as his current positions on the boards of several prominent biotechnology …

Shimmick Awarded $124M Flood Project Covering About Nine Miles

Shimmick (NASDAQ: SHIM) has announced over $265 million in new project awards, significantly expanding its backlog. Key projects include a $124 million flood protection project in San José, a $42 million wastewater treatment plant expansion in Texas, and an $80 million share in the …

Altimmune Market Sentiment

This article provides an overview of the market sentiment for Altimmune (ALT), including analyst consensus, short interest, options flow, and insider activity. It highlights a strong "Buy" consensus from analysts with ambitious price targets and notes a significant short interest of 24.5%. The article …

Immunocore Holdings PLC (IMCR) Cash Flow

This article provides a detailed cash flow statement for Immunocore Holdings PLC (IMCR), covering operating, investing, and financing activities across various quarters and fiscal years. It includes specific financial figures and percentage changes for different cash flow components. Additionally, the article offers FAQs explaining …

Lyell Immunopharma Inc (LYEL) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Lyell Immunopharma Inc (LYEL), covering operating, investing, and financing activities. It presents financial data for various quarters, highlighting net income, capital expenditures, and changes in working capital. The report also includes FAQs …

Immatics NV (IMTX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Immatics NV (IMTX), listing its major shareholders and their proportional holdings. It also provides a breakdown of shareholder types, institutional shareholding data over several quarters, and recent shareholder activity from key investors. Additionally, the article identifies related …

SCNI|Scinai Immunotherapeutics Ltd|Price:0.245|Chg%:-0.014

Scinai Immunotherapeutics Ltd (SCNI) is a biopharmaceutical company focused on developing medical products for autoimmune and infectious diseases, particularly NanoAbs for conditions like COVID-19 and psoriasis. Despite a recent stock price decline, the company shows strong fundamentals and significant growth potential, although analysts currently …

Immunic Inc (IMUX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Immunic Inc (IMUX). It states that the company has not distributed any dividends in the past five years. However, it lists a significant 10-for-1 merger type stock split scheduled for April 14, 2026.

Immuron Ltd (IMRN) Institutional Confidence

This article focuses on the institutional confidence in Immuron Ltd (IMRN), detailing the shareholding and activity of various financial institutions. Key institutions like Morgan Stanley & Co. LLC and Citadel Advisors LLC significantly increased their holdings, while others like XTX Markets LLC and Rhumbline …

96,341 Shares in BitMine Immersion Technologies, Inc. $BMNR Acquired by Entropy Technologies LP

Entropy Technologies LP has acquired 96,341 shares of BitMine Immersion Technologies Inc. (BMNR) during the first quarter, valued at around $1.91 million. Other institutional investors like Sumitomo Mitsui Trust Group also increased their holdings. Although analyst sentiment for BMNR is mixed but leans positive, …

Scinai Immunotherapeutics Ltd (SCNI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Scinai Immunotherapeutics Ltd (SCNI). It notes that SCNI has distributed $0.00 in dividends over the past five years and details several merger-related stock splits with a 10:1 ratio that occurred in May 2024 and …

Estrella Immunopharma Inc (ESLA) Balance Sheet

This article provides detailed quarterly and annual balance sheet data for Estrella Immunopharma Inc (ESLA), allowing investors to analyze its financial health, liquidity, leverage, and return on equity. The balance sheet includes metrics such as cash and short-term investments, total assets, various liabilities, and …

ImmuCell Corp (ICCC) Cash Flow

This article provides an in-depth look at ImmuCell Corp's (ICCC) cash flow statements, including operating, investing, and financing activities, across various fiscal quarters and years. It also defines key cash flow metrics like operating, investing, and financing cash flow, as well as free cash …

BitMine Immersion Technologies (NYSE:BMNR) Shares Gap Up - Here's What Happened

Estrella Immunopharma Inc (ESLA) Cash Flow - Tradingkey.com

This article provides a detailed cash flow statement for Estrella Immunopharma Inc (ESLA), presenting quarterly and annual financial data for operating, investing, and financing activities. It includes key metrics like operating cash flow, net income, and changes in working capital, along with definitions for …